Robbins Farley’s Exact Sciences EXAS Stock Holding History

Robbins Farley’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11	Closed	-$465	–	163
2024 Q2	$465	Hold	11	–	–	﹤0.01%	148
2024 Q1	$760	Hold	11	–	–	﹤0.01%	143
2023 Q4	$814	Buy	+11	New	+$721	﹤0.01%	145

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Robbins Farley's EXAS Position: Q3 2024 in Review

Robbins Farley sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 11 shares — an estimated $465 sold.

Robbins Farley first reported a position in EXAS in Q4 2023 and held it in 3 quarters. The position peaked at $814 in Q4 2023. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

Robbins Farley reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
Robbins Farley sold 11 Exact Sciences shares in Q3 2024, an estimated $465.
Robbins Farley first reported a position in Exact Sciences in Q4 2023 and held it in 3 quarters.
Robbins Farley's Exact Sciences position peaked at $814 in Q4 2023.
599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Robbins Farley's 13F filing for Q3 2024, filed 16 Oct 2024.